Published in Vaccine Weekly, July 17th, 2002
This phase I/II trial was conducted in 35 adolescent patients ages 12-17 years with insulin-dependent type I diabetes to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.